Previous Close | 225.49 |
Open | 225.86 |
Bid | 218.16 x 1200 |
Ask | 218.68 x 800 |
Day's Range | 217.44 - 226.76 |
52 Week Range | 203.37 - 460.21 |
Volume | |
Avg. Volume | 549,593 |
Market Cap | 11.047B |
Beta (5Y Monthly) | 1.27 |
PE Ratio (TTM) | 26.50 |
EPS (TTM) | 8.20 |
Earnings Date | Aug 02, 2022 - Aug 08, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 327.64 |
Charles River's (CRL) industry knowledge in plasmid DNA production will benefit Ziphius Vaccines' early-stage saRNA manufacturing program.
It is hard to get excited after looking at Charles River Laboratories International's (NYSE:CRL) recent performance...
WILMINGTON, Mass. & MACCLESFIELD, England, June 28, 2022--Charles River announces the opening of their High Quality Plasmid DNA Centre of Excellence at Bruntwood SciTech’s Alderley Park.